Veterinary and Comparative Oncology

Papers
(The TQCC of Veterinary and Comparative Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats141
Determining agreement between preoperative computed tomography lymphography and indocyanine green near infrared fluorescence intraoperative imaging for sentinel lymph node mapping in dogs with oral tu29
Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs21
Peripheral blood cell ratios as prognostic factors in canine diffuse large B‐cell lymphoma treated withCHOPprotocol18
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report17
To map or not to map the cN0 neck: Impact of sentinel lymph node biopsy in canine head and neck tumours16
Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate15
Neutrophil‐to‐lymphocyte ratio is an independent prognostic marker for feline mammary carcinomas14
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retro14
Clinical presentation, treatment and outcome of canine malignant mesothelioma: A retrospective study of 34 cases13
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019)13
Statins downregulateYAPandTAZand exert anti‐cancer effects in canine mammary tumour cells13
Prognostic impact of clinical, haematological, and histopathological variables in 102 canine cutaneous perivascular wall tumours12
Diagnosis and histopathologic prognostication of canine melanocytic neoplasms: A consensus of the Oncology‐Pathology Working Group12
Adjuvant doxorubicin vs metronomic cyclophosphamide and meloxicam vs surgery alone for cats with mammary carcinomas: A retrospective study of 137 cases12
Characterizing the molecular and immune landscape of canine bladder cancer12
The effect of cannabidiol on canine neoplastic cell proliferation and mitogen‐activated protein kinase activation during autophagy and apoptosis11
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria11
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross‐sectional analysis of Dog Aging Project baseline survey11
Outcome, prognostic factors and histological characterization of canine gastrointestinal sarcomas11
Long non‐coding RNA and transfer RNA‐derived small fragments in exosomes are potential biomarkers for canine oral melanoma10
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review10
A newly established canine NK‐type cell line and its cytotoxic properties9
Prognostic value of immunohistochemical markers in canine cutaneous mast cell tumours: A systematic review and meta‐analysis9
Canine presumed glial brain tumours treated with radiotherapy: Is there an inferior outcome in tumours contacting the subventricular zone?9
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)9
Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvantCSPG4‐antig9
Intraoperative assessment of canine soft tissue sarcoma by deep learning enhanced optical coherence tomography9
Histologic grade has a higher‐weighted value than nodal status as predictor of outcome in dogs with cutaneous mast cell tumours and overtly metastatic sentinel lymph nodes9
Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T‐cell lymphomas8
Molecular differences in mitochondrial DNA genomes of dogs with malignant mammary tumours8
The oncogenic pathways of papillomaviruses8
Risk of bladder cancer and lymphoma in dogs is associated with pollution indices by county of residence8
Post‐operative complications following apocrine gland anal sac adenocarcinoma resection in dogs8
Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case–control study8
Prognostic indicators for naïve canine non‐indolent T‐cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy7
Minimally invasive ethyl cellulose ethanol ablation in domesticated cats with naturally occurring head and neck cancers: Six cats7
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol7
Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential7
Outcome and postoperative complications in 73 dogs with thyroid carcinoma with gross vascular invasion managed with thyroidectomy7
Extensive staging has no prognostic value in dogs with low‐risk mast cell tumours7
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factors7
Genetic variants of BRCA1 and BRCA2 genes in cats with mammary gland carcinoma7
Response‐based modification of CHOP chemotherapy for canine B‐cell lymphoma7
The selective inhibitor of nuclear export (SINE) verdinexor exhibits biologic activity against canine osteosarcoma cell lines7
Ki‐67 assessment—agreeability between immunohistochemistry and flow cytometry in canine lymphoma6
Shear wave elastography of lymph nodes in dogs with head and neck cancer: A pilot study6
Are B‐symptoms more reliable prognostic indicators than substage in canine nodal diffuse large B‐cell lymphoma6
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review6
Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas6
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway6
Plasma 25‐hydroxyvitamin D and the inflammatory response in canine cancer6
Thymic epithelial tumours in 51 dogs: Histopathologic and clinicopathologic findings6
JARID1‐targeted histone H3 demethylase inhibitors exhibit anti‐proliferative activity and overcome cisplatin resistance in canine oral melanoma cell lines6
Inter‐pathologist agreement on diagnosis, classification and grading of canine glioma6
Feline and canine Merkel cell carcinoma: A case series and discussion on cellular origin6
Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component6
A prospective, multi‐centre, Veterinary Radiation Therapy Oncology Group study reveals potential efficacy of toceranib phosphate (Palladia) as a primary or adjuvant agent in the treatment of canine na6
Efficacy and adverse events of continuousl‐asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin6
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma6
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy5
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment5
Using digital RNA counting to establish flow cytometry diagnostic criteria for subtypes of CD34+ canine acute leukaemia5
Response of canine thyroid carcinomas to radioiodine5
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs5
Oncolytic effect of Newcastle disease virus is attributed to interferon regulation in canine mammary cancer cell lines5
Long‐term outcomes with conventional fractionated and stereotactic radiotherapy for suspected heart‐base tumours in dogs5
A retrospective study and survival analysis on bitches with mammary tumours spayed at the same time of mastectomy5
Comparison of pathologist review protocols for cytologic detection of prostatic and urothelial carcinomas in canines: A bi‐institutional retrospective study of 298 cases5
Retrospective assessment of radiation toxicity from a definitive‐intent, moderately hypofractionated image‐guided intensity‐modulated protocol for anal sac adenocarcinoma in dogs5
Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology5
CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles5
Axillary lymphadenectomy in dogs: A description of surgical technique5
Highly recurrent BRAF p.V595E mutation in canine papillary oral squamous cell carcinoma5
Focused ultrasound tumour ablation in small animal oncology5
Blood biomarkers for canine cancer, from human to veterinary oncology5
Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma4
Familial follicular cell thyroid carcinomas in a large number of Dutch German longhaired pointers4
KIT mutations in mast cell tumours from cheetahs (Acinonyx jubatus) and domestic cats (Felis catus)4
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma4
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines4
Total laryngectomy and permanent tracheostomy in six dogs4
DNA damage response proteins in canine cancer as potential research targets in comparative oncology4
A retrospective analysis of 11 dogs with surface osteosarcoma4
SLUG is upregulated and induces epithelial mesenchymal transition in canine oral squamous cell carcinoma4
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours4
The second‐generation curcumin analogue RL71 elicits G2/M cell cycle arrest and apoptosis in canine osteosarcoma cells4
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients4
Liquid biopsy can detect BRCA2 gene variants in female dogs with mammary neoplasia4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology4
0.035753965377808